BridgeBio Oncology Therapeutics, Inc. (BBOT) ROE
- 2026-06-30: ROE -56.36%.
- 2026-03-31: ROE -41.39%.
- 2025-12-31: ROE -32.61%.
- 2025-09-30: ROE -25.73%.
Complete source-backed roe history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | -56.36% |
| 2026-03-31 | -41.39% |
| 2025-12-31 | -32.61% |
| 2025-09-30 | -25.73% |
| 2025-06-30 | 38.42% |
| 2025-03-31 | 40.44% |
| 2024-12-31 | 41.58% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -32.61% |
| 2024-12-31 | 41.58% |
| 2023-12-31 | 0.04% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |